Literature DB >> 32633880

Multidrug resistant organism predicts ulcer recurrence following surgical management of diabetic foot osteomyelitis.

Brian M Schmidt1, Wen Ye2, Shiwei Zhou3.   

Abstract

Diabetic foot ulcers commonly precede diabetic foot osteomyelitis (DFO) and once the latter occurs, surgical management is often performed. The presence of osteomyelitis is an independent risk factor for the development of re-ulceration. We investigated the relationship between causative organisms in osteomyelitis and 1-year diabetic foot outcomes (re-ulceration, amputation, and death) following surgical management in an observational cohort of 223 patients. Univariate and multivariate analyses were performed for available demographic, clinical, and laboratory data. In addition, random forest plots were used to identify microbiologic predictors of 1-year outcomes. Patients with osteomyelitis managed surgically were younger and exhibited more painful peripheral neuropathy than outpatients with diabetes alone (both P < .0001). Osteomyelitis proximal margin cultures were diverse, at times polymicrobial, and included multidrug-resistant organisms in 13.9% of the cohort. In patients who underwent surgery, 44.5% experienced a re-ulceration on the same foot within 12 months of surgery. The presence of multidrug-resistant organisms on proximal bone culture was found to be a significant predictor of diabetic foot ulcer recurrence in univariate modelling (P < .001) and importance rankings. This is the first study to use prediction modelling to identify a relationship between multidrug-resistant organisms and diabetic foot ulcer recurrence following DFO.
© 2020 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  amputation; diabetic foot osteomyelitis; diabetic foot ulcer; multidrug-resistant organisms; ulcer recurrence

Mesh:

Year:  2020        PMID: 32633880      PMCID: PMC7736527          DOI: 10.1111/iwj.13439

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  28 in total

1.  Rate of residual osteomyelitis after partial foot amputation in diabetic patients: a standardized method for evaluating bone margins with intraoperative culture.

Authors:  Said Atway; Vincent S Nerone; Kevin D Springer; Darren M Woodruff
Journal:  J Foot Ankle Surg       Date:  2012-07-21       Impact factor: 1.286

2.  2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; Paul B Cornia; James C Pile; Edgar J G Peters; David G Armstrong; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Michael S Pinzur; Eric Senneville
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

3.  Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem.

Authors:  C N Dang; Y D M Prasad; A J M Boulton; E B Jude
Journal:  Diabet Med       Date:  2003-02       Impact factor: 4.359

4.  Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients.

Authors:  I Mantey; R L Hill; A V Foster; S Wilson; J J Wade; M E Edmonds
Journal:  Commun Dis Public Health       Date:  2000-12

5.  Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.

Authors:  A Hartemann-Heurtier; J Robert; S Jacqueminet; G Ha Van; J L Golmard; V Jarlier; A Grimaldi
Journal:  Diabet Med       Date:  2004-07       Impact factor: 4.359

6.  Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.

Authors:  Marina Claros; Diane M Citron; Ellie J C Goldstein; C Vreni Merriam; Kerin L Tyrrell
Journal:  Diagn Microbiol Infect Dis       Date:  2013-05-30       Impact factor: 2.803

7.  Influence of multidrug resistant organisms on the outcome of diabetic foot infection.

Authors:  Nese Saltoglu; Onder Ergonul; Necla Tulek; Mucahit Yemisen; Ayten Kadanali; Gul Karagoz; Ayse Batirel; Oznur Ak; Cagla Sonmezer; Haluk Eraksoy; Atahan Cagatay; Serkan Surme; Salih A Nemli; Tuna Demirdal; Omer Coskun; Derya Ozturk; Nurgul Ceran; Filiz Pehlivanoglu; Gonul Sengoz; Turan Aslan; Yasemin Akkoyunlu; Oral Oncul; Hakan Ay; Lutfiye Mulazımoglu; Buket Erturk; Fatma Yilmaz; Gulsen Yoruk; Nuray Uzun; Funda Simsek; Taner Yildirmak; Kadriye Kart Yaşar; Meral Sonmezoglu; Yasar Küçükardali; Nazan Tuna; Oguz Karabay; Nail Ozgunes; Fatma Sargın
Journal:  Int J Infect Dis       Date:  2018-02-21       Impact factor: 3.623

8.  Multidrug resistant organism predicts ulcer recurrence following surgical management of diabetic foot osteomyelitis.

Authors:  Brian M Schmidt; Wen Ye; Shiwei Zhou
Journal:  Int Wound J       Date:  2020-07-07       Impact factor: 3.315

9.  Soluble factors from biofilms of wound pathogens modulate human bone marrow-derived stromal cell differentiation, migration, angiogenesis, and cytokine secretion.

Authors:  Catherine L Ward; Carlos J Sanchez; Beth E Pollot; Desiree R Romano; Sharanda K Hardy; Sandra C Becerra; Christopher R Rathbone; Joseph C Wenke
Journal:  BMC Microbiol       Date:  2015-03-28       Impact factor: 3.605

10.  Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial Therapy.

Authors:  Oryan Henig; Jason M Pogue; Raymond Cha; Paul E Kilgore; Umar Hayat; Mahmoud Ja'ara; Raza Muhamad Ali; Salman Mahboob; Rahul Pansare; Kathryn Deeds; Bushra Joarder; Hyndavi Kandala; Sorabh Dhar; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2018-09-27       Impact factor: 3.835

View more
  2 in total

Review 1.  Metagenomics to Identify Pathogens in Diabetic Foot Ulcers and the Potential Impact for Clinical Care.

Authors:  Brian M Schmidt; John Erb-Downward; Piyush Ranjan; Robert Dickson
Journal:  Curr Diab Rep       Date:  2021-06-21       Impact factor: 4.810

2.  Multidrug resistant organism predicts ulcer recurrence following surgical management of diabetic foot osteomyelitis.

Authors:  Brian M Schmidt; Wen Ye; Shiwei Zhou
Journal:  Int Wound J       Date:  2020-07-07       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.